VS
Vanaja Sankula
About Vanaja Sankula
Data last updated:
Vanaja Sankula is a Director at Sunrise Biosciences Private Limited (since 2023). The company operates in Pharma. Sunrise Biosciences Private Limited reported revenue of ₹12.28 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunrise Biosciences Private Limited U46497TS2023PTC172036 | Director | 18 Apr 2023 | 2023 | ₹12.28 Cr (FY 2024) | Active |
Board colleagues of Vanaja Sankula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kakumani Ravichandra | 11175760 | Sunrise Biosciences Private Limited | Additional Director |
| Kiran Mai Ganta | 10120384 | Sunrise Biosciences Private Limited | Director |
| Siva Bhaskara Paturi Naren | 08061855 | Sunrise Biosciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vanaja Sankula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vanaja Sankula
Vanaja Sankula currently holds 1 directorship: Sunrise Biosciences Private Limited (Director, since 18 Apr 2023, revenue ₹12.28 Cr (FY 2024)).
Vanaja Sankula was first appointed on 18 Apr 2023 as Director at Sunrise Biosciences Private Limited.
The current boards of Vanaja Sankula's companies include Kakumani Ravichandra (Sunrise Biosciences Private Limited), Kiran Mai Ganta (Sunrise Biosciences Private Limited), Siva Bhaskara Paturi Naren (Sunrise Biosciences Private Limited).